Transmission-Blocking Vaccines for Malaria: Time to Talk about Vaccine Introduction.

Trends Parasitol 2019 Jul 29;35(7):483-486. Epub 2019 May 29.

Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD, USA. Electronic address:

Malaria kills more than 600 000 people yearly, mainly children, and eradication is a global priority. Malaria transmission-blocking vaccines are advancing in clinical trials, and strategies for their introduction must be prioritized among stakeholders and the vulnerable populations exposed to the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pt.2019.04.008DOI Listing
July 2019
9 Reads

Publication Analysis

Top Keywords

transmission-blocking vaccines
8
yearly children
4
children eradication
4
eradication global
4
prioritized stakeholders
4
people yearly
4
clinical trials
4
000 people
4
introduction prioritized
4
global priority
4
trials strategies
4
advancing clinical
4
vaccines advancing
4
strategies introduction
4
priority malaria
4
malaria transmission-blocking
4
600 000
4
stakeholders vulnerable
4
vaccine introduction
4
exposed disease
4

Similar Publications